Prestige Consumer Healthcare, Inc. (PBH)
52.47
+1.26
(+2.46%)
USD |
NYSE |
Aug 28, 16:00
52.46
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Free Cash Flow : 235.36M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 235.36M |
| March 31, 2026 | 246.45M |
| December 31, 2025 | 267.19M |
| September 30, 2025 | 255.45M |
| June 30, 2025 | 267.84M |
| March 31, 2025 | 243.29M |
| December 31, 2024 | 248.69M |
| September 30, 2024 | 254.64M |
| June 30, 2024 | 246.39M |
| March 31, 2024 | 239.38M |
| December 31, 2023 | 232.04M |
| September 30, 2023 | 215.70M |
| June 30, 2023 | 211.34M |
| March 31, 2023 | 221.93M |
| December 31, 2022 | 225.47M |
| September 30, 2022 | 236.40M |
| June 30, 2022 | 239.68M |
| March 31, 2022 | 250.28M |
| December 31, 2021 | 244.51M |
| September 30, 2021 | 223.94M |
| June 30, 2021 | 208.57M |
| March 31, 2021 | 213.36M |
| December 31, 2020 | 207.03M |
| September 30, 2020 | 218.30M |
| June 30, 2020 | 221.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 199.80M |
| December 31, 2019 | 199.45M |
| September 30, 2019 | 185.95M |
| June 30, 2019 | 176.24M |
| March 31, 2019 | 178.80M |
| December 31, 2018 | 182.86M |
| September 30, 2018 | 183.86M |
| June 30, 2018 | 199.39M |
| March 31, 2018 | 197.58M |
| December 31, 2017 | 152.40M |
| September 30, 2017 | 149.67M |
| June 30, 2017 | 146.52M |
| March 31, 2017 | 144.80M |
| December 31, 2016 | 175.28M |
| September 30, 2016 | 180.75M |
| June 30, 2016 | 177.89M |
| March 31, 2016 | 170.78M |
| December 31, 2015 | 183.62M |
| September 30, 2015 | 183.38M |
| June 30, 2015 | 163.72M |
| March 31, 2015 | 150.15M |
| December 31, 2014 | 131.06M |
| September 30, 2014 | 111.22M |
| June 30, 2014 | 116.84M |
| March 31, 2014 | 108.82M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Indivior Pharmaceuticals, Inc. | -119.51M |
| ANI Pharmaceuticals, Inc. | 167.52M |
| Corcept Therapeutics, Inc. | 106.92M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 22.61B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 70.79M |
| Cash from Investing (Quarterly) | -1.064B |
| Cash from Financing (Quarterly) | 1.018B |
| Free Cash Flow Per Share (Quarterly) | 1.409 |
| Free Cash Flow to Equity (Quarterly) | -954.92M |
| Free Cash Flow to Firm (Quarterly) | 77.64M |
| Free Cash Flow Yield | 9.31% |